• SPX
  • 5969.34
  • 0.35 %
  • 20.6299
  • DJI
  • 44296.51
  • 0.97 %
  • 426.1602
  • N225
  • 38283.85
  • 0.68 %
  • 257.6797
  • FTSE
  • 8262.08
  • 1.38 %
  • 112.8101
  • IXIC
  • 19003.65
  • 0.16 %
  • 31.2305
Helius Medical Technologies, Inc. (HSDT) Stock Price, News & Analysis

Helius Medical Technologies, Inc. (HSDT) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.45

-$0

(0.6%)

Day's range
$0.45
Day's range
$0.51
50-day range
$0.373
Day's range
$0.8444
  • Country: US
  • ISIN: US42328V8019
52 wk range
$0.37
Day's range
$9.5


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -48.25
  • Piotroski Score 1.00
  • Grade Buy
  • Symbol (HSDT)
  • Company Helius Medical Technologies, Inc.
  • Price $0.45
  • Changes Percentage (0.6%)
  • Change -$0
  • Day Low $0.45
  • Day High $0.51
  • Year High $9.50

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/13/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$13.22
  • Trailing P/E Ratio -0.09
  • Forward P/E Ratio -0.09
  • P/E Growth -0.09
  • Net Income $-8,850,000

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Helius Medical Technologies, Inc. Frequently Asked Questions

  • What were the earnings of HSDT in the last quarter?

    In the last quarter Helius Medical Technologies, Inc. earnings were on Tuesday, November, 12th. The Helius Medical Technologies, Inc. maker reported -$0.99 EPS for the quarter, beating analysts' consensus estimates of -$1.06 by $0.07.

  • What is the Helius Medical Technologies, Inc. stock price today?

    Today's price of Helius Medical Technologies, Inc. is $0.45 — it has decreased by 0.6% in the past 24 hours. Watch Helius Medical Technologies, Inc. stock price performance more closely on the chart.

  • Does Helius Medical Technologies, Inc. release reports?

    Yes, you can track Helius Medical Technologies, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Helius Medical Technologies, Inc. stock forecast?

    Watch the Helius Medical Technologies, Inc. chart and read a more detailed Helius Medical Technologies, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Helius Medical Technologies, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Helius Medical Technologies, Inc. stock ticker.

  • How to buy Helius Medical Technologies, Inc. stocks?

    Like other stocks, HSDT shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Helius Medical Technologies, Inc.'s EBITDA?

    Helius Medical Technologies, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Helius Medical Technologies, Inc.’s financial statements.

  • What is the Helius Medical Technologies, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -13.7422360248, which equates to approximately -1,374.22%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Helius Medical Technologies, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Helius Medical Technologies, Inc.'s financials relevant news, and technical analysis. Helius Medical Technologies, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Helius Medical Technologies, Inc. stock currently indicates a “sell” signal. For more insights, review Helius Medical Technologies, Inc.’s technical analysis.

  • A revenue figure for Helius Medical Technologies, Inc. for its last quarter?

    Helius Medical Technologies, Inc. published it's last quarterly revenues at $51,000.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.